The neurologists behind every decision
Your manuscript is handled by named experts in clinical and translational neurology: a board of 18 researchers and clinicians across 7 countries, led by a subject Editor-in-Chief.
Editor-in-Chief
Zheng Jiang
Baylor College of Medicine, Houston, USA
Neural/retinal electrophysiology
Formerly: Research Associate in Neuroscience, Johns Hopkins University School of Medicine.
Editorial board members
Subject experts across epilepsy, neurodegeneration, stroke and neurovascular biology, neurotrauma and clinical neurophysiology. Each decision on your manuscript is signed by a named editor in the relevant field.
Joslin Diabetes Center (Harvard Medical School affiliate), Boston, MA, USA
Neurovascular biology & stroke
0009-0003-0279-4035 
Dr (University of Florence)
Neurology, Hospital S. Giovanni di Dio, Florence, Italy
Epilepsy & antiepileptic drugs
0000-0002-2416-147X 
MD PHD MSC FACADTM PCTM, FSASS
Oasi Research Institute IRCCS, Troina, Italy
Clinical neurophysiology & epilepsy
0000-0002-8358-0885 
Houston Methodist Research Institute, Houston, TX, USA
Neurodegeneration & DNA-damage repair
0000-0001-7333-8123 
Neurodegeneration
Editors are listed as recorded by the journal; ORCID is shown where the editor has registered one. Board members join and rotate over time, so we keep this page current rather than padded.
Have your work judged by experts in the field
A named, subject-matter board, Single-blind (double-blind on request) peer review, and a first decision in about three weeks. Read the guidelines, then submit.